Infarmed, Portugal’s medicines regulator is mapping pharmaceutical innovations expected to hit the market over the next two years with a new horizon scanning initiative. The project will help authorities in Portugal prioritize new treatments and speed up market entry.
As part of the project, some 200 companies have been asked to submit details of the reimbursement applications that they expect to file over 2018 and 2019 for new active...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?